Ross Cummings

FierceBiotech Executive Summit

On Tuesday 30 October, Ross Cummings will be attending the FierceBiotech Executive Summit at the Royal Society of Medicine. The half-day summit will gather industry experts to discuss the infrastructures of biomedical sciences across the UK and the challenges and opportunities to the life sciences sector amid a time of...

Read more

UK Bioscience Forum

On Thursday 18 October, Ross Cummings will be attending the UK Bioscience Forum at the Queen Elizabeth II Conference Centre in Westminster. The forum, hosted by the BIA, will be a day filled with presentations and panel discussions which will focus on the practical and key issues for the bioscience...

Read more

In a new age of personalised cancer therapy, is patent law in Europe still fit for purpose?

In the last week it has been announced that the NHS has struck a deal with Novartis to offer their ground-breaking new CAR-T therapy, Kymriah®, to paediatric patients with B cell acute lymphoblastic leukaemia. This is a significant development and means that some patients will now have access to this...

Read more

Pilots4U Workshop

Ross Cummings will be speaking at the Pilots4U Workshop ‘Scale me up, Scotty’ on 18 April in Brussels. The workshop will present and discuss different open access cooperation models and highlight common agreements regarding Intellectual property rights. The workshop intends to inform (and discuss with) pilot infrastructure owners and users...

Read more

Asking the right questions to optimise life sciences IP

This article was originally published on Biotech and Money. Supporting commercial goals by asking ‘why?’ As there is no one-size-fits-all approach to developing an effective IP strategy, GJE ensures it has a thorough understanding of its clients’ objectives and developments within their businesses so that it is able to offer the...

Read more